{"id":1039314,"date":"2024-01-12T02:33:51","date_gmt":"2024-01-12T07:33:51","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/thermo-fisher-unveils-its-largest-and-most-ethnically-diverse-array-for-pharmacogenomic-research-bsa-bureau\/"},"modified":"2024-08-17T16:26:19","modified_gmt":"2024-08-17T20:26:19","slug":"thermo-fisher-unveils-its-largest-and-most-ethnically-diverse-array-for-pharmacogenomic-research-bsa-bureau","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/thermo-fisher-unveils-its-largest-and-most-ethnically-diverse-array-for-pharmacogenomic-research-bsa-bureau.php","title":{"rendered":"Thermo Fisher unveils its largest and most ethnically diverse array for pharmacogenomic research &#8211; BSA bureau"},"content":{"rendered":"<p><p>    American supplier Thermo Fisher Scientific has launched the new    Axiom PangenomiX Array, its largest and most ethnically diverse    array to date, offering optimal genetic coverage for population    scale disease studies and pharmacogenomic research.  <\/p>\n<p>    The PangenomiX Array is currently the only research solution    that combines four assays in one test: SNP genotyping, whole    genome copy number variant detection, fixed copy number    discovery, blood and HLA typing. The high-throughput array is    designed to advance disease risk and detection research,    population-scale disease research programs, ancestry and    wellness testing, drug efficacy testing, and drug development    research.  <\/p>\n<p>    Inclusive of clinically relevant pharmacogenomic markers and    pathogenic variants, the PangenomiX Array offers researchers    enhanced whole-genome imputation and a high level of diversity    for testing different ethnicities to keep pace with the growing    understanding of the genome. The array has already been used to    analyse nearly half a million ethnically diverse samples at a    predominant biobank in the US to advance more inclusive    research studies related to the prevention, diagnosis and    treatment of disease.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.biospectrumasia.com\/news\/89\/23545\/thermo-fisher-unveils-its-largest-and-most-ethnically-diverse-array-for-pharmacogenomic-research.html\" title=\"Thermo Fisher unveils its largest and most ethnically diverse array for pharmacogenomic research - BSA bureau\" rel=\"noopener\">Thermo Fisher unveils its largest and most ethnically diverse array for pharmacogenomic research - BSA bureau<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> American supplier Thermo Fisher Scientific has launched the new Axiom PangenomiX Array, its largest and most ethnically diverse array to date, offering optimal genetic coverage for population scale disease studies and pharmacogenomic research. The PangenomiX Array is currently the only research solution that combines four assays in one test: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood and HLA typing. The high-throughput array is designed to advance disease risk and detection research, population-scale disease research programs, ancestry and wellness testing, drug efficacy testing, and drug development research <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/thermo-fisher-unveils-its-largest-and-most-ethnically-diverse-array-for-pharmacogenomic-research-bsa-bureau.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246862],"tags":[],"class_list":["post-1039314","post","type-post","status-publish","format-standard","hentry","category-pharmacogenomics"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1039314"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1039314"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1039314\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1039314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1039314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1039314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}